{"id":"https://openalex.org/W2547428409","doi":"https://doi.org/10.1200/jco.2016.68.2807","title":"Association Between Out-Of-Pocket Costs, Race/Ethnicity, and Adjuvant Endocrine Therapy Adherence Among Medicare Patients With Breast Cancer","display_name":"Association Between Out-Of-Pocket Costs, Race/Ethnicity, and Adjuvant Endocrine Therapy Adherence Among Medicare Patients With Breast Cancer","publication_year":2017,"publication_date":"2017-01-01","ids":{"openalex":"https://openalex.org/W2547428409","doi":"https://doi.org/10.1200/jco.2016.68.2807","mag":"2547428409","pmid":"https://pubmed.ncbi.nlm.nih.gov/28034069","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5455689"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2016.68.2807","doi":"https://doi.org/10.1200/jco.2016.68.2807","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2016.68.2807","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5455689","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051810152","display_name":"Albert John Farias","orcid":"https://orcid.org/0000-0002-6463-7831","observed_orcids":["https://orcid.org/0000-0002-6463-7831"]},"institutions":[{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Albert J. Farias","raw_affiliation_strings":["All authors: The University of Texas Health Science Center at Houston, Houston, TX","Department of Epidemiology, Human Genetics, and Environmental Sciences, UTHealth School of Public Health, 1200 Pressler St, Houston, TX, 77030;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"All authors: The University of Texas Health Science Center at Houston, Houston, TX","institution_ids":["https://openalex.org/I919571938"]},{"raw_affiliation_string":"Department of Epidemiology, Human Genetics, and Environmental Sciences, UTHealth School of Public Health, 1200 Pressler St, Houston, TX, 77030;","institution_ids":["https://openalex.org/I919571938"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031411629","display_name":"Xianglin L. Du","orcid":"https://orcid.org/0000-0003-0119-5252","observed_orcids":["https://orcid.org/0000-0003-0119-5252"]},"institutions":[{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xianglin L. Du","raw_affiliation_strings":["All authors: The University of Texas Health Science Center at Houston, Houston, TX","Department of Epidemiology, Human Genetics, and Environmental Sciences, UTHealth School of Public Health, 1200 Pressler St, Houston, TX, 77030;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"All authors: The University of Texas Health Science Center at Houston, Houston, TX","institution_ids":["https://openalex.org/I919571938"]},{"raw_affiliation_string":"Department of Epidemiology, Human Genetics, and Environmental Sciences, UTHealth School of Public Health, 1200 Pressler St, Houston, TX, 77030;","institution_ids":["https://openalex.org/I919571938"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5051810152"],"corresponding_institution_ids":["https://openalex.org/I919571938"],"apc_list":null,"apc_paid":null,"fwci":18.672,"has_fulltext":false,"cited_by_count":108,"citation_normalized_percentile":{"value":0.991183,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"35","issue":"1","first_page":"86","last_page":"95"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.6172000169754028,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.6172000169754028,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.34860000014305115,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10556","display_name":"Global Cancer Incidence and Screening","score":0.008799999952316284,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adjuvant-endocrine-therapy","display_name":"adjuvant endocrine therapy","score":0.9160000085830688},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.7559999823570251},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.8989999890327454},{"id":"https://openalex.org/keywords/out-of-pocket-costs","display_name":"out-of-pocket costs","score":0.9760000109672546},{"id":"https://openalex.org/keywords/racial-and-ethnic-disparities","display_name":"racial and ethnic disparities","score":0.8500000238418579},{"id":"https://openalex.org/keywords/medicare-part-d","display_name":"Medicare Part D","score":0.675000011920929},{"id":"https://openalex.org/keywords/tamoxifen","display_name":"tamoxifen","score":0.9589999914169312},{"id":"https://openalex.org/keywords/aromatase-inhibitors","display_name":"aromatase inhibitors","score":1.0},{"id":"https://openalex.org/keywords/hormone-receptor-positive-breast-cancer","display_name":"hormone receptor-positive breast cancer","score":0.9139999747276306},{"id":"https://openalex.org/keywords/medication-possession-ratio","display_name":"medication possession ratio","score":0.781000018119812},{"id":"https://openalex.org/keywords/hispanic-patients","display_name":"Hispanic patients","score":0.5519999861717224},{"id":"https://openalex.org/keywords/black-patients","display_name":"Black patients","score":0.8769999742507935},{"id":"https://openalex.org/keywords/socioeconomic-factors","display_name":"socioeconomic factors","score":0.4819999933242798},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.5550000071525574},{"id":"https://openalex.org/keywords/seer-medicare","display_name":"SEER-Medicare","score":0.671999990940094},{"id":"https://openalex.org/keywords/older-adults","display_name":"older adults","score":0.4620000123977661},{"id":"https://openalex.org/keywords/poverty-status","display_name":"poverty status","score":0.5389999747276306},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.8370000123977661}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9372366666793823},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6880077719688416},{"id":"https://openalex.org/C137403100","wikidata":"https://www.wikidata.org/wiki/Q41710","display_name":"Ethnic group","level":2,"score":0.6048685312271118},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6039254665374756},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5339741706848145},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.5319051742553711},{"id":"https://openalex.org/C76509639","wikidata":"https://www.wikidata.org/wiki/Q918036","display_name":"Race (biology)","level":2,"score":0.5153626799583435},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4822588562965393},{"id":"https://openalex.org/C46699223","wikidata":"https://www.wikidata.org/wiki/Q11078","display_name":"Endocrine system","level":3,"score":0.45301276445388794},{"id":"https://openalex.org/C2777982462","wikidata":"https://www.wikidata.org/wiki/Q2481887","display_name":"Adjuvant therapy","level":3,"score":0.4279044270515442},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.3534463047981262},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.2429564893245697},{"id":"https://openalex.org/C19165224","wikidata":"https://www.wikidata.org/wiki/Q23404","display_name":"Anthropology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.0},{"id":"https://openalex.org/C59822182","wikidata":"https://www.wikidata.org/wiki/Q441","display_name":"Botany","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001213","descriptor_name":"Asian","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D001741","descriptor_name":"Black or African American","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":false},{"descriptor_ui":"D005006","descriptor_name":"Ethnicity","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D005102","descriptor_name":"Health Expenditures","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006278","descriptor_name":"Medicare","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D006630","descriptor_name":"Hispanic or Latino","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012959","descriptor_name":"Socioeconomic Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013629","descriptor_name":"Tamoxifen","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D013629","descriptor_name":"Tamoxifen","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017024","descriptor_name":"Chemotherapy, Adjuvant","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D018426","descriptor_name":"SEER Program","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D018931","descriptor_name":"Antineoplastic Agents, Hormonal","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D018931","descriptor_name":"Antineoplastic Agents, Hormonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D044465","descriptor_name":"White People","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D047072","descriptor_name":"Aromatase Inhibitors","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D047072","descriptor_name":"Aromatase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D055118","descriptor_name":"Medication Adherence","qualifier_ui":"Q000208","qualifier_name":"ethnology","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1200/jco.2016.68.2807","doi":"https://doi.org/10.1200/jco.2016.68.2807","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2016.68.2807","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5455689","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5455689","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Clin Oncol","raw_type":"Text"},{"id":"pmid:28034069","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28034069","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:5455689","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5455689","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Clin Oncol","raw_type":"Text"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"},{"score":0.9629999995231628,"id":"https://metadata.un.org/sdg/10","display_name":"Reduced inequalities"}],"sustainable_development_goals_aurora":[{"score":0.8100000023841858,"id":"https://metadata.un.org/sdg/1","display_name":"No poverty"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G4935307590","display_name":"Addressing Disparities in Breast Cancer Outcomes among Hispanic Women","funder_award_id":"F31CA174338","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G6265598773","display_name":"Behavioral Science Education - Cancer Prevention and Control","funder_award_id":"R25CA057712","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G8919812274","display_name":"COMPARATIVE EFFECTIVENESS AND COST EFFECTIVENESS OF CANCER CHEMOTHERAPY","funder_award_id":"R01HS018956","funder_id":"https://openalex.org/F4320332177","funder_display_name":"Agency for Healthcare Research and Quality"}],"funders":[{"id":"https://openalex.org/F4320332177","display_name":"Agency for Healthcare Research and Quality","ror":"https://ror.org/03jmfdf59"},{"id":"https://openalex.org/F4320332205","display_name":"Centers for Medicare and Medicaid Services","ror":"https://ror.org/02g02rq35"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":48,"referenced_works":["https://openalex.org/W1509574557","https://openalex.org/W1540562253","https://openalex.org/W1603749692","https://openalex.org/W1845225129","https://openalex.org/W1967204277","https://openalex.org/W1967542511","https://openalex.org/W1996337195","https://openalex.org/W2000445173","https://openalex.org/W2009439253","https://openalex.org/W2011966376","https://openalex.org/W2012942082","https://openalex.org/W2015338056","https://openalex.org/W2019458473","https://openalex.org/W2034100757","https://openalex.org/W2041732919","https://openalex.org/W2044702943","https://openalex.org/W2045087507","https://openalex.org/W2055535124","https://openalex.org/W2060656611","https://openalex.org/W2063626928","https://openalex.org/W2071003201","https://openalex.org/W2078340902","https://openalex.org/W2078486195","https://openalex.org/W2080062875","https://openalex.org/W2096092145","https://openalex.org/W2101944829","https://openalex.org/W2102314359","https://openalex.org/W2102823761","https://openalex.org/W2105630607","https://openalex.org/W2118728607","https://openalex.org/W2121656289","https://openalex.org/W2127604901","https://openalex.org/W2134839096","https://openalex.org/W2142753818","https://openalex.org/W2148009360","https://openalex.org/W2154734961","https://openalex.org/W2154835844","https://openalex.org/W2154877455","https://openalex.org/W2157875208","https://openalex.org/W2161426850","https://openalex.org/W2161977537","https://openalex.org/W2163688875","https://openalex.org/W2166846975","https://openalex.org/W2169902698","https://openalex.org/W2318545861","https://openalex.org/W2397748587","https://openalex.org/W2806628538","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2553046504","https://openalex.org/W3122116691","https://openalex.org/W3048459096","https://openalex.org/W2500857994","https://openalex.org/W2902182912","https://openalex.org/W2808809481","https://openalex.org/W7023618236","https://openalex.org/W2950294388","https://openalex.org/W2590046803","https://openalex.org/W4308773027"],"abstract_inverted_index":{"Purpose":[0],"Previous":[1],"studies":[2],"suggest":[3],"that":[4],"adherence":[5,40,154,181,200,255,286],"to":[6,31,41,63,85,108,140,182,192,201,210,237,246,271],"adjuvant":[7],"endocrine":[8],"therapy":[9,263],"(AET)":[10],"for":[11,98,103,144,155,218,230,275],"patients":[12,65],"with":[13,24,71,149,161,213,264],"breast":[14,74],"cancer":[15,75],"is":[16,22],"suboptimal,":[17],"especially":[18],"among":[19],"minorities,":[20],"and":[21,43,94,113,194,222,278,296],"associated":[23,148],"out-of-pocket":[25,45,297],"medication":[26,123,146,298],"costs.":[27,299],"This":[28,54],"study":[29,57],"aimed":[30],"determine":[32],"whether":[33,44],"there":[34],"are":[35],"racial/ethnic":[36,49],"differences":[37,292],"in":[38,51,79,284,293],"1-year":[39],"AET":[42,99,115,145,184,262,285],"costs":[46,97,143],"explain":[47],"the":[48,59,122,129,162,173,224],"disparities":[50,283],"adherence.":[52],"Methods":[53],"retrospective":[55],"cohort":[56,88],"used":[58],"SEER-Medicare":[60],"linked":[61],"database":[62],"identify":[64],"\u2265":[66],"65":[67],"years":[68],"of":[69,153,165,180,199,254],"age":[70],"hormone":[72],"receptor-positive":[73],"who":[76],"were":[77,101,138,147,287],"enrolled":[78],"Medicare":[80],"Part":[81],"D":[82],"from":[83],"2007":[84],"2009.":[86],"The":[87],"included":[89],"non-Hispanic":[90,214,257],"whites,":[91],"blacks,":[92],"Hispanics,":[93],"Asians.":[95],"Out-of-pocket":[96,142],"medications":[100],"standardized":[102],"a":[104],"30-day":[105],"supply.":[106],"Adherence":[107],"tamoxifen,":[109],"aromatase":[110],"inhibitors":[111],"(AIs),":[112],"overall":[114],"(tamoxifen":[116],"or":[117,239],"AIs)":[118],"was":[119,226],"assessed":[120],"using":[121],"possession":[124],"ratio":[125],"(\u2265":[126],"80%)":[127],"during":[128],"12-month":[130],"period.":[131],"Results":[132],"Of":[133],"8,688":[134],"patients,":[135],"3,197":[136],"(36.8%)":[137],"nonadherent":[139],"AET.":[141],"lower":[150,251],"adjusted":[151,252],"odds":[152,179,198,253],"all":[156],"four":[157],"cost":[158],"categories":[159],"compared":[160,212],"lowest":[163],"category":[164],"\u2264":[166],"$2.65":[167],"(":[168],"P":[169],"<":[170],".01).":[171],"In":[172],"univariable":[174],"analysis,":[175],"Hispanics":[176,231],"had":[177,196,249],"higher":[178,197],"any":[183],"at":[185,203],"initiation":[186,204],"(OR,":[187,205,232,241,266],"1.30;":[188],"95%":[189,207,234,243,268],"CI,":[190,208,235,244,269],"1.07":[191],"1.57),":[193],"blacks":[195,240],"AIs":[202],"1.27;":[206],"1.04":[209],"1.54)":[211],"whites.":[215],"After":[216],"adjusting":[217,274],"copayments,":[219],"poverty":[220],"status,":[221],"comorbidities,":[223],"association":[225],"no":[227],"longer":[228],"significant":[229],"0.95;":[233],"0.78":[236],"1.17)":[238],"0.96;":[242],"0.77":[245],"1.19).":[247],"Blacks":[248],"significantly":[250],"than":[256],"whites":[258],"when":[259],"they":[260],"initiated":[261],"tamoxifen":[265],"0.54;":[267],"0.31":[270],"0.93)":[272],"after":[273],"socioeconomic,":[276],"clinic,":[277],"prognostic":[279],"factors.":[280],"Conclusion":[281],"Racial/ethnic":[282],"largely":[288],"explained":[289],"by":[290],"women's":[291],"socioeconomic":[294],"status":[295]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":16},{"year":2022,"cited_by_count":16},{"year":2021,"cited_by_count":15},{"year":2020,"cited_by_count":13},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-11-11T00:00:00"}